0000899243-20-031574.txt : 20201118 0000899243-20-031574.hdr.sgml : 20201118 20201118195146 ACCESSION NUMBER: 0000899243-20-031574 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201116 FILED AS OF DATE: 20201118 DATE AS OF CHANGE: 20201118 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PARRISH MARK W CENTRAL INDEX KEY: 0001236452 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39695 FILM NUMBER: 201326712 MAIL ADDRESS: STREET 1: BUILDING 4, TRIDENT PLACE STREET 2: MOSQUITO WAY CITY: HATFIELD, HERTFORDSHIRE STATE: X0 ZIP: AL10 9UL ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Viatris Inc CENTRAL INDEX KEY: 0001792044 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 834364296 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1000 MYLAN BOULEVARD CITY: CANONSBURG STATE: PA ZIP: 15317 BUSINESS PHONE: (724) 514-1465 MAIL ADDRESS: STREET 1: 1000 MYLAN BOULEVARD CITY: CANONSBURG STATE: PA ZIP: 15317 FORMER COMPANY: FORMER CONFORMED NAME: Upjohn Inc DATE OF NAME CHANGE: 20191023 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-11-16 0 0001792044 Viatris Inc VTRS 0001236452 PARRISH MARK W 1000 MYLAN BOULEVARD CANONSBURG PA 15317 1 0 0 0 Common Stock 2020-11-16 4 A 0 58295 A 58313 D Non-Employee Director Stock Option - Right to Buy 45.72 2020-11-16 4 A 0 2974 A 2024-04-11 Common Stock 2974 2974 D Non-Employee Director Stock Option - Right to Buy 50.66 2020-11-16 4 A 0 2603 A 2025-11-17 Common Stock 2603 2603 D Non-Employee Director Stock Option - Right to Buy 46.27 2020-11-16 4 A 0 2788 A 2026-02-17 Common Stock 2788 2788 D Non-Employee Director Stock Option - Right to Buy 45.18 2020-11-16 4 A 0 2928 A 2027-03-03 Common Stock 2928 2928 D Non-Employee Director Stock Option - Right to Buy 40.97 2020-11-16 4 A 0 2984 A 2028-03-02 Common Stock 2984 2984 D Non-Employee Director Stock Option - Right to Buy 27.45 2020-11-16 4 A 0 4352 A 2029-03-01 Common Stock 4352 4352 D Non-Employee Director Stock Option - Right to Buy 17.48 2020-11-16 4 A 0 6151 A 2030-03-02 Common Stock 6151 6151 D Restricted Stock Units 0.00 2020-11-16 4 A 0 9440 A Common Stock 9440 9440 D On November 16, 2020, Mylan N.V. ("Mylan") completed the transaction pursuant to which Mylan combined with Pfizer Inc.'s ("Pfizer") Upjohn business (the "Upjohn Business") in a Reverse Morris Trust transaction (the "Combination") and Upjohn Inc. ("Upjohn") became the parent entity of the combined Upjohn Business and Mylan business and was renamed "Viatris Inc." ("Viatris"). Pursuant to the terms of the Business Combination Agreement (as amended), dated July 29, 2019, by and among Mylan, Pfizer, Upjohn and certain other affiliated entities, Upjohn and Mylan effected the Combination through a series of transactions, including that each holder of Mylan ordinary shares received one share of Viatris common stock for each Mylan ordinary share held by such holder (subject to any required withholding tax). Represents shares of Viatris common stock acquired in connection with the Combination on a one-for-one basis in exchange for ordinary shares of Mylan. On the effective date of the Combination, the closing price of a Mylan ordinary share was $15.85 per share. Includes 18 shares of common stock acquired in the distribution on November 16, 2020 by Pfizer to its stockholders of all of the issued and outstanding shares of Upjohn common stock held by Pfizer by way of pro rata dividend. Received in exchange for, and having substantially the same terms as, stock options to acquire Mylan ordinary shares in connection with the Combination. These options vested on April 11, 2015. These options vested on May 1, 2016. These options vested on February 17, 2017. These options vested on March 3, 2018. These options vested on March 2, 2019. These options vested on March 2, 2020. These options will vest on March 2, 2021. Received in exchange for, and having substantially the same terms as, restricted stock units ("RSUs") of Mylan in connection with the Combination. Each RSU represents the right to receive one share of common stock of Viatris. The RSUs will vest on March 2, 2021. /s/ Kevin Macikowski, by power of attorney 2020-11-18